Trends in tissue engineering for blood vessels

Judee Grace Nemeno-Guanzon1, Soojung Lee, Johan Robert Berg

  • 1Regenerative Medicine Laboratory, Stem Cell Research Center, Department of Biomedical Science and Technology, SMART Institute of Advanced Biomedical Science, Konkuk University, 143-701 Seoul, Republic of Korea.

Insights

Advancements in biofabrication and tissue engineering offer promising solutions for cardiovascular diseases, particularly for creating tissue-engineered blood vessels. This research highlights recent progress in stem cell therapies and scaffold-based approaches for vascular reconstruction.

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Cardiovascular Research

Background:

  • Cardiovascular diseases represent a growing global health and economic burden.
  • Traditional blood vessel transplantation faces limitations due to donor scarcity and patient-specific issues.
  • Tissue engineering presents a viable alternative for treating vascular defects.

Observation:

  • Biofabrication technologies are crucial for advancing soft tissue defect treatments, especially for vascular tissues.
  • Recent progress focuses on tissue reconstruction using autologous stem cells, scaffolds, and scaffold-free constructs.
  • The last decade has seen significant evolution in blood vessel tissue engineering techniques.

Findings:

  • Tissue-engineered blood vessels are emerging as promising alternatives to traditional transplantation.
  • The integration of stem cell biology and advanced biofabrication is key to developing effective vascular grafts.
  • Current research trends emphasize patient-specific regenerative strategies.

Implications:

  • This work underscores the importance of biofabrication in addressing the need for effective cardiovascular disease treatments.
  • Future developments in tissue engineering could alleviate shortages in donor tissues and improve patient outcomes.
  • Continued research in stem cell-based vascular reconstruction holds significant therapeutic potential.